Citizens Jmp upgraded shares of KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) to a strong-buy rating in a report ...

American Tower (NYSE:AMT – Get Free Report) was upgraded by investment analysts at Citizens Jmp to a “strong-buy” rating in a ...

Epistrophy Capital Research chief market strategist Cory Johnson and head of Citizens JMP Mark Lehmann join Julie ... and share their outlooks for the company. Johnson argues that Intel continues ...

GH Research PLC (GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a ...

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression. GH Research PLC's initial focus ...

JMP Securities maintained its Market Outperform rating on Century Casinos shares (NASDAQ:CNTY) with a set price target of $5.00. The firm highlighted Century Casinos' potential as an attractive merger ...

Perella Weinberg Partners (NASDAQ: PWP) Q4 2024 Earnings Call Transcript February 7, 2025 Perella Weinberg Partners misses on ...

Bally’s Corporation (NYSE: BALY; BALY.T) (“Bally’s” or the “Company”) today announced that it has completed the previously ...

The buy now/pay later lender outperformed nearly every analyst estimate in its fiscal Q2 2025 earnings report. CEO Max Levchin said the company is 5 months out from positive GAAP operating income.